View poster
Using a proteomics-based cardiovascular risk test to identify systemic changes in a clinical trial of ... nonalcoholic fatty liver disease
POSTER
2 of 6
Using a proteomics-based cardiovascular risk test to identify systemic changes in a clinical trial of ...
POSTER
Liquid Liver biopsy
POSTER
Predicting fibrotic NASH or at-risk NASH, with the SomaScan® Assay
TECH NOTE
Predicting fibrotic NASH or at-risk NASH, with the SomaScan® Assay
TECH NOTE
Liquid Liver biopsy
POSTER
Using a proteomics-based cardiovascular risk test to identify systemic changes in a clinical trial of ...
POSTER
Liquid liver biopsy
POSTER
Predicting fibrotic NASH or at-risk NASH, with the SomaScan® Assay
TECH NOTE
Liquid Liver biopsy
POSTER
Using a proteomics-based cardiovascular risk test to identify systemic changes in a clinical trial of ...
POSTER
Predicting Fibrotic or At-Risk MASH, with the SomaScan Assay
TECH NOTE
SomaScan® 11K Assay v5
TECH NOTE
SomaScan® 11K Assay v5.0
TECH NOTE
SomaScan Assay Services
PAGE
SomaSignal Tests
PAGE
SomaScan Assay services
PAGE
SomaSignal Tests
PAGE
SomaScan® 11K Assay v5
TECH NOTE
SomaSignal Tests
PAGE
SomaScan Assay services
PAGE
SomaSignal Tests
PAGE
SomaScan® 11K Assay v5
TECH NOTE
SomaScan Assay services
PAGE
3 of 6
1 of 6
4 of 6
5 of 6
6 of 6
View poster
View tech note
View tech note
Learn more
Learn more